Azenta, Inc. (NASDAQ:AZTA) Stock Position Raised by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC increased its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 21.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,915,556 shares of the company's stock after purchasing an additional 337,675 shares during the quarter. Conestoga Capital Advisors LLC owned about 4.19% of Azenta worth $66,355,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AZTA. Net Worth Advisory Group lifted its stake in shares of Azenta by 56.4% in the 1st quarter. Net Worth Advisory Group now owns 6,644 shares of the company's stock worth $230,000 after acquiring an additional 2,397 shares during the period. SG Americas Securities LLC raised its holdings in Azenta by 90.6% during the first quarter. SG Americas Securities LLC now owns 30,972 shares of the company's stock worth $1,073,000 after purchasing an additional 14,719 shares in the last quarter. Farther Finance Advisors LLC lifted its position in Azenta by 788.1% in the first quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock worth $33,000 after purchasing an additional 859 shares during the period. GAMMA Investing LLC boosted its stake in Azenta by 4,054.6% during the 1st quarter. GAMMA Investing LLC now owns 65,019 shares of the company's stock valued at $2,252,000 after purchasing an additional 63,454 shares in the last quarter. Finally, Alpha Wealth Funds LLC acquired a new position in shares of Azenta during the 4th quarter valued at $225,000. Institutional investors own 99.08% of the company's stock.

Azenta Stock Down 1.0%

Azenta stock traded down $0.30 during mid-day trading on Friday, hitting $29.64. The company's stock had a trading volume of 901,287 shares, compared to its average volume of 702,501. The stock has a market capitalization of $1.36 billion, a P/E ratio of -21.32 and a beta of 1.62. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The stock's fifty day moving average price is $27.47 and its two-hundred day moving average price is $38.90.

Azenta (NASDAQ:AZTA - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.30% and a negative net margin of 10.31%. During the same period last year, the firm earned $0.06 earnings per share. The company's revenue was up 5.1% compared to the same quarter last year. Equities analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

AZTA has been the subject of several research analyst reports. Needham & Company LLC cut their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. TD Cowen upgraded shares of Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.